All Pharma articles – Page 14
-
NewsSpecialised commissioning process 'lacks transparency', NHS England told
Specialised commissioning is “very hard to probe”, resulting in “unusual decisions”, stakeholders warn NHS England made funding U-turn on two treatments it had previously deemed “unaffordable” but provided little detail about why FOI request for minutes of specialised commissioning funding body denied ABPI says “major reassessment” of whole process ...
-
HSJ KnowledgeCancer drugs webinar: How to put a value on the priceless
A webinar in association with Roche brought together senior figures to consider how we assess the value of sophisticated drugs when the area is such an intellectual and moral maze. Report by Claire Read
-
NewsExclusive: Stevens backs major £400m medicines savings drive
NHS England backs plan to eliminate prescribing of “low priority” medicines worth up to £400m Commissioners to tackle spending on “low priority” medicines including gluten-free products and paracetamol that can be bought over the counter First phase of plan looks to eliminate £128m spending on 10 items Commissioning leader ...
-
NewsNICE goes ahead with controversial drug affordability test
NICE approves plans to defer treatment implementation if the cost per year is higher than £20m in any of the first three years of implemention Consultation responses warn that this could lead to treatment access “inequity” especially for those with rare diseases New “light touch” fast-track appraisal method also ...
-
NewsCourt defeat moves NHS England to clarify treatments policy
NHS England says court case has led to confusion among funding request applications Judge said last year that NHS England policy was “absurd” New policy will set out clear guidance on exceptionality test for patients NHS England says it will clarify its policy on commissioning treatments for patients ...
-
News'Wholly inappropriate' NHS England appeal thrown out of court
NHS England loses Court of Appeal bid and must pay costs Father accuses national commissioning body of “bully boy” approach Judge says there was “no good reason in the public interest” for the appeal to proceed NHS England is facing a £200,000 legal bill after pursuing a court ...
-
News
CCG warns against pharma giant's vaccine offer
Dudley CCG warns GPs over buying discounted vaccines directly from Sanofi The manufacturer is offering GPs a 50 per cent discount on flu vaccines GPs are then reimbursed by the NHS Business Services Authority at full price CCG says this may have “negative” impact for taxpayers Commissioners in ...
-
HSJ KnowledgeSpecialist nurses support cost effective drugs for treatment
Specialist IBD nurses are key to ensuring cutting edge biological therapies are used in a way which benefits both trust and patient
-
HSJ KnowledgeHow specialist nurses can bring services closer to home
Shrewd service redesign by specialist nurses can lead to greater efficiency for providers and better care for patients
-
CommentPreparing for the impact of Brexit on health in the UK
In the aftermath of Brexit, it is essential that the NHS gain public support for the continued recruitment of clinical and scientific staff from the EU
-
CommentReframing frailty care – what can we learn from mental health?
Four challenges must be overcome if society and NHS decision makers are to heed the valuable lessons from another sector
-
HSJ KnowledgeRoundtable: Jumping the hurdles to better care in rare diseases
An HSJ roundtable sponsored by Shire brought together experts to ask whether the NHS was taking advantage of all the factors that could improve outcomes for patients with rare diseases. By Alison Moore
-
NewsHSJ Value in Healthcare Awards shortlist revealed
The organisations in the running to win one of the HSJ Value in Healthcare Awards 2017 at have been revealed.
-
HSJ LocalCCGs to impose temporary ban on prescribing expensive treatments
CCGs agree 18 month moratorium on individual funding requests as part of £1m savings package Greater Huddersfield and North Kirklees CCGs have approved the proposal, which is expected to save £750,000. Plans to stop prescribing products such as gluten free foods are expected to save a further £283,000 a ...
-
NewsNHS England to press ahead with court appeal
NHS England has agreed to commission sodium oxybate routinely for children with narcolepsy NHS England will continue with Court of Appeal bid over judicial review decision to prescribe the same drug to a child High Court said the national body’s decision was “thoroughly bad” and ordered to commission 17 ...
-
NewsDepartment of Health offers £220k salary for new commercial chief
Department seeks pharma heavyweight to lead on commercial strategy Post holder will lead renegotiation of the pharmaceutical pricing regulatory scheme Salary would make post holder one of the department’s highest earners The Department of Health is recruiting for a new chief commercial officer, with a £220,000 basic salary ...
-
NewsNHS England loses landmark drug appeal
Court of Appeal upholds judgment that NHS England has power to commission PrEP If NHS England commissions drug it could result in other treatments earmarked for funding not being commissioned Judge criticises Lansley reforms for creating “bureacratic squabbles” between NHS and local government on funding responsibilitie NHS England ...
-
Expert BriefingFollowing the Money: NHS England moves its tanks
HSJ’s weekly email briefing on NHS finances, savings and efforts to get the health service back in the black
-
HSJ KnowledgeWebinar on demand: Making tough decisions on anti-cancer therapies
How can we best make difficult decisions about patient value and financial cost?
-
NewsDrugs to face new NHS affordability test
NICE and NHS England consult on “budget impact test” for new treatments Test designed to mitigate impact of cost effective but highly expensive drugs on NHS England’s budget NICE also proposes cost effectiveness threshold for assessment of drugs for rare conditions The National Institute for Health and Care ...